ArticleBMC microbiology2025
Detection and antimicrobial susceptibility of E. coli O157:H7 in the milk supply chain, milking environments and humans in Woliata Sodo, Ethiopia.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundEscherichia coli O157:H7 is a strain that produces Shiga toxin, which can cause infections ranging from mild to severe in humans. Cattle are a primary reservoir for the bacteria, and the contaminated milk and milk products can transmit these bacteria to humans, posing a risk of infection. The present study aimed to evaluate the occurrence of E. coli O157:H7 and determine its antimicrobial susceptibility profile across the milk supply chain, milking environments, and humans in Woliata Sodo, Southern Ethiopia. METHODOLOGY: A total of 644 samples, including raw milk, hand swabs, teat swabs, equipment swabs, floor swabs, and human stool, were collected through a cross sectional study. Bacterial detection was performed according to the ISO 16,654 standard method, and the antimicrobial susceptibility of the isolates was evaluated using the Kirby-Bauer disk diffusion method against 14 antimicrobials representing ten different classes.
resultsThe overall detection rate of E. coli O157:H7 was 3.1% (20/644). The highest detection rate was observed in milk samples collected at milk collecting centers, at 10% (5/50). In comparison, detection rates were 6.8% (4/59) in samples from milkers' hands, 5.4% (2/37) in farm floor swabs, and 2.9% among outpatients presenting with diarrhea. All the isolates showed resistance to doxycycline, erythromycin, tetracycline, clindamycin, and vancomycin. Additionally, 95%, 90%, and 90% of isolates were resistant to amoxicillin, ampicillin, and streptomycin, respectively. Resistance was lower for ceftriaxone (20%) and chloramphenicol (15%). A significant proportion (100%) of the isolates exhibited multidrug resistance.
conclusionThis study confirmed the presence of multidrug resistant E. coli O157:H7 in the tested sample. Notably, the highest prevalence was detected in milk samples from collection centers, underscoring post harvest contamination as a critical point of intervention. Identification of the pathogen on milkers' hands, farm floors, and human stool samples highlights potential transmission pathways and suggests a tangible risk of foodborne infections. These findings emphasize the critical need for targeted public health strategies, including comprehensive education on hygienic practices and the implementation of effective contamination control measures, to reduce the risk of infection and protect consumer health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.